The global market for Total Hip Arthroplasty (THA) has witnessed robust structural growth, fueled by aging populations, a rise in degenerative joint disease cases, and an increasing clinical preference for active lifestyle retention in younger demographics. Total hip reconstruction implants represent one of the most critical segments of the orthopedic device sector, characterized by tight regulatory thresholds, complex metallurgy, and high demands for bio-inert surfaces. As global healthcare supply chains shift toward high-efficiency, cost-optimized, and certified manufacturing nodes, distributors and medical brands face the task of sourcing clinically proven, CE-certified components that minimize risks of aseptic loosening or prosthetic revision.
Transition from traditional metals to titanium alloys (Ti6Al4V) and advanced tribological couples (Ceramic-on-Highly Crosslinked Polyethylene) to drastically reduce wear debris and extend implant longevity up to 25+ years.
With the transition from MDD to EU MDR (2017/745), traceability, clinical evaluation reports (CER), and rigorous quality management audits are vital to secure risk-free entry into European and associated global markets.
Modern orthopedic procurement hinges on precision CNC machining, laser welding, and automated metrology, reducing lead times while guaranteeing uniform tolerance control down to the sub-micron scale.
China's advanced orthopedic manufacturing sector has transitioned from simple component replication to intelligent, high-precision engineering. Underpinned by integrated industrial clusters, access to medical-grade titanium and cobalt-chromium alloys, and a large pool of trained biomedical engineers, Chinese factories offer an optimal cost-to-performance ratio. At Synoviq Medical, this efficiency is translated into direct benefits for global buyers: high-throughput CNC capabilities, vertical integration of surface treatment (including plasma-sprayed coatings and grit blasting), and streamlined compliance documentation that eliminates regulatory bottlenecks.
Synoviq Medical Technology (China) Co., Ltd. is a professional manufacturer of orthopedic implants and surgical instruments, dedicated to delivering innovative, reliable, and high-quality medical solutions for healthcare professionals worldwide. Since its establishment, Synoviq has focused on research, development, precision manufacturing, and international quality standards, providing comprehensive OEM and ODM services for global medical device brands, distributors, and hospitals.
Our product portfolio includes trauma fixation systems, spinal implants, locking plates, intramedullary nails, external fixation systems, orthopedic screws, surgical instruments, and customized orthopedic solutions. Equipped with advanced CNC machining centers, precision inspection equipment, and modern clean production facilities, we ensure every product meets strict international quality requirements.
Driven by continuous innovation, Synoviq invests heavily in R&D and intelligent manufacturing to enhance product performance, surgical efficiency, and patient outcomes. Our experienced engineering team works closely with customers to develop customized products tailored to different clinical applications and market demands. With a customer-oriented philosophy, competitive pricing, stable supply capability, and efficient technical support, Synoviq has established long-term partnerships with distributors, medical brands, and healthcare organizations across Europe, North America, South America, the Middle East, and Asia-Pacific.
| Item | Information |
|---|---|
| Company Name | Synoviq Medical Technology (China) Co., Ltd. |
| Brand | Synoviq |
| Established | March 18, 2016 |
| Building Area | 18,600 m² |
| Annual Export Revenue | USD 21.8 Million |
| Export Experience | 8 Years |
| Industry Experience | 14 Years |
| Quality Inspection | 100% Final Inspection & Incoming Material Inspection |
| Product Inspection Methods | CMM Measurement, Mechanical Testing, Surface Roughness Testing, Hardness Testing, Salt Spray Testing, Sterility Validation |
| Quality Control Staff | 48 |
| Business Type | Manufacturer & Exporter (OEM/ODM) |
| Main Markets | Europe, North America, South America, Middle East, Southeast Asia |
| Supply Chain Partners | 1,120+ |
| Main Customer Types | Medical Device Brands, Importers, Distributors, Hospitals, Government Procurement Projects |
| R&D Capability | Independent Product Design, Prototype Development, Clinical-Oriented Engineering, OEM & ODM Development |
| Customization Options | Logo Customization, Packaging Customization, Product Design Customization, Material Selection, Surface Treatment |
| New Products Released Last Year | 186 |
| R&D Engineers | 76 |
Every medical implant fabricated under the Synoviq brand undergoes rigorous quality control throughout each production phase. Our facilities are equipped with leading manufacturing machinery and precision testing gear to ensure dimensional stability, mechanical endurance, and bio-safety.
Orthopedic implants are not one-size-fits-all. Different demographics, clinical centers, and anatomical constraints require customized mechanical profiles. Recognizing these challenges, Synoviq Medical develops medical implants configured for diverse physiological settings, addressing specific pain points faced by procurement managers globally.
Designed for patients undergoing primary total hip arthroplasty due to osteoarthritis or avascular necrosis. Our press-fit, cementless stems utilize porous plasma-sprayed titanium surfaces that promote rapid, direct bone-apposition, minimizing the risk of early migration.
For cases involving severe bone loss or previous implant failure. Our modular revision stems and acetabular structural augments allow surgeons to reconstruct complex anatomical shapes, restoring stable joint centers of rotation.
Providing precision-engineered solutions tailored for veterinary practices. Our range of specialized canine and feline micro-hip replacement implants ensures veterinary surgeons achieve anatomically accurate fits for animal joint arthrosis.
The future of total hip joint replacement lies in the integration of digital planning, smart materials, and patient-specific manufacturing. Over the next decade, the industry is projected to shift toward:
We follow strict ASTM and ISO guidelines for medical titanium alloy testing. Our on-site mechanical laboratory carries out fatigue, compression, and shear testing. Dynamic load fatigue tests are conducted to verify that our hip stems can withstand millions of load cycles without mechanical failure, simulating decades of physiological use.
For standard orthopedic plates, intramedullary nails, and hip components, production lead times average 30 to 45 days, depending on batch volumes and sterilization specifications. For fully customized implants (ODM), the prototype design, finite element analysis (FEA), and trial production stages typically take 60 to 90 days.
Yes, our engineering team ensures that taper dimensions (such as standard 12/14 tapers) and thread designs are compatible with established global instrument systems. We also supply customized surgical instrument sets matching our implants to facilitate smooth operating room procedures.
We provide several surface treatments tailored to clinical requirements, including titanium plasma spray (TPS), hydroxyapatite (HA) coating, micro-abrasive blasting, and anodic oxidation. These coatings enhance bio-compatibility, promote osseointegration, and support long-term secondary stability.
Synoviq Medical
